U.S. COMPANY FILING
PFIZER INC — Form 10-K filed 2026-02-26
Filing text preview
Pfizer's 2025 total revenues were $62.6 billion, down 2% year-over-year, primarily due to lower Paxlovid sales. Net income was $7.77 billion, with diluted EPS of $1.36. The company completed the acquisition of Metsera and continued cost-cutting programs. Risks include patent expiries, IRA pricing reforms, and tariffs.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record